In vitro, they reported that metformin treatment increased FOXO1 protein levels, decreased inhibitory FOXO1 phosphorylation, and increased FOXO1 nuclear accumulation in an AMPK-dependent manner, resulting in inhibition of endometrial cancer cell proliferation. This evidence concerns the gene FOXO1 and endometrial cancer.